The Effect of Two Different Bathing Methods on Vital Signs and Comfort in PICU:Bath Trial

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age28-18
SponsorIzmir Katip Celebi University

About this trial

The study was planned to be conducted and completed within 6 months after ethics committee approval was obtained. The study is a prospective, quasi-experimental study.

The population of the study will consist of children who are hospitalized in the Pediatric Intensive Care Unit of SBÜ. İzmir Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital. The vital signs and comfort of the children of the parents who agreed to participate in the study will be measured before bathing (baseline) and care will be taken to ensure that they are similar in both groups.

Children in the study will not be randomized. In the routine operation of the clinic, traditional bathing is performed once a week and wipe bathing is performed once every two days. Wipe bathing is performed at 36-37 degrees water with 10 ml of chlorhexidine in 200 ml of water. Traditional bathing is also performed with 36-37 degrees water in bed or in the bathtub. In the study, no intervention will be performed and the outcomes will be measured and compared with each other before and after both bathing procedures.

Physiologic parameters including respiratory rate, pulse rate, oxygen saturation and comfort levels of newborns just before, during and after the bathing process (1st and 5th minute) will be evaluated and compared with each other. To avoid bias in the study, all bathing procedures will be performed by Specialist Nurse Esat Erdem GÖKPINAR.

Translated with DeepL.com (free version)

Eligibility criteria

Qualifiers

Being hospitalized in Behçet Uz Pediatric Intensive Care Unit

No contraindications to bathing

Parent's willingness to participate in the study

Disqualifiers

Having a contraindication to bathing

Parents were not willing to participate in the study

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

52 Participants
are grouped into 2 trial groups

Sponsors and collaborators